Clinical Trials Browser

Phase 2 × OTHER × NOV 002 × Clear all

NCT00499122 2018-01-02

NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer

Phase 2 Completed

41 enrolled 10 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00960726 2012-07-30

NOV-002 in Myelodysplastic Syndrome (MDS)

Phase 2 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes